CN Stock MarketDetailed Quotes

688319 Chengdu Olymvax Biopharmaceuticals Inc

Watchlist
  • 9.10
  • +0.16+1.79%
Market Closed Apr 30 15:00 CST
3.70BMarket Cap-303333P/E (TTM)

Chengdu Olymvax Biopharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Chengdu Olymvax Biopharmaceuticals Inc Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 26, 2024

Revenue(YoY)

70.80M

+5.87%
EPS(YoY)

-0.06

-774.74%
Analyst Rating

Strong Buy

May 3, 2024

Chengdu Olymvax Biopharmaceuticals Inc Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.079B--
--2024/FY-- / 658.000M--
--2023/FY496.119M / 632.763M--
--2022/FY547.481M / 595.000M--
--2021/FY487.152M / 513.000M--
--2020/FY320.109M / ----
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.079B--
--2024/FY-- / 658.000M--
--2023/FY496.119M / 632.763M--
--2022/FY547.481M / 595.000M--
--2021/FY487.152M / 513.000M--
--2020/FY320.109M / ----
--------
--------
--------
--------

Unlock Free Earnings Estimates

Chengdu Olymvax Biopharmaceuticals Inc Earnings Reports

  • Summary of the 2023 Annual Report of Chengdu Olin Biotechnology Co., Ltd.

    Apr 26 00:00

  • Chengdu Olin Biotechnology Co., Ltd. 2023 Annual Report

    Apr 26 00:00

  • Chengdu Olin Biotechnology Co., Ltd. Report for the first quarter of 2024

    Apr 26 00:00

  • Chengdu Olin Biotechnology Co., Ltd. 2023 Annual Results Express Announcement

    Feb 28 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: May 3, 2024

    Strong Buy

    • Strong Buy

      66.67%

    • Buy

      33.33%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg